SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

ACADIA Pharmaceuticals Q1 EPS $(0.570) Misses $(0.480) Estimate, Sales $90.068M Miss $91.510M Estimate

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported quarterly losses of $(0.570) per share which missed the analyst consensus estimate of $(0.480) by 18.75 percent. This is a 3.39 percent increase over losses of $(0.590) per

Benzinga · 05/07/2020 21:02

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported quarterly losses of $(0.570) per share which missed the analyst consensus estimate of $(0.480) by 18.75 percent. This is a 3.39 percent increase over losses of $(0.590) per share from the same period last year. The company reported quarterly sales of $90.068 million which missed the analyst consensus estimate of $91.510 million by 1.58 percent. This is a 43.06 percent increase over sales of $62.959 million the same period last year.